A Retrospective and Prospective Natural History of Genetic Vasculopathies

Recruiting Observational Study
Multisystemic Smooth Muscle Dysfunction Syndrome ACTA2
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
29 Days and older
Sex
Any
Study type
Observational
Participants needed
50 (estimated)
Sponsor
Massachusetts General Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study will combine retrospective review of medical records from patients with ACTA2 and ongoing collection of clinical data using standardized instruments and intervals on an observational basis from patients with ACTA2. Patients in cohorts 1-3 will be asked to attend clinic visits in person per the schedule of events. At minimum, the medical records of patients with ACTA2 will be reviewed t…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Confirmed ACTA2 pathogenic variant * Available medical records since birth that permit documentation of disease characteristics and developmental milestone * Have two parents and/or legal guardians who are English speaking and are able to read, understand, and sign the informe…
Contacts

Anna V Lynch, BA

617-949-6960

alynch22@mgh.harvard.edu

CONTACT

Diana Tambala, MD

dtambala@mgh.harvard.edu

CONTACT